Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec 7;96(25):14493-8.
doi: 10.1073/pnas.96.25.14493.

Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow

Affiliations

Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow

S Dejbakhsh-Jones et al. Proc Natl Acad Sci U S A. .

Abstract

We have identified a rare ( approximately 0.05-0.1%) population of cells (Thy-1(hi)CD16(+)CD44(hi)CD2(-)TCRalphabeta(-)B220(-)M ac-1(-)NK1. 1(-)) in the adult mouse bone marrow that generates CD4(+) and CD8(+) TCRalphabeta(+) T cells after tissue culture for 48 hr in the presence of Ly5 congenic marrow cells. The essential stages in the maturation of the progenitors were determined; the stages included an early transition from CD2(-)CD16(+)CD44(hi)TCRalphabeta(-) to CD2(+)CD16(int/-)CD44(int/-)TCRalphabeta(-) cells, and a later transition to CD4(+)CD8(+)TCRalphabeta(+) double-positive T cells that rapidly generate the CD4(+) and CD8(+) single-positive T cells. The maturation of the progenitors is almost completely arrested at the CD2(+)TCRalphabeta(-) stage by the presence of mature T cells at the initiation of cultures. This alternate pathway is supported by the marrow microenvironment; it recapitulates critical intermediary steps in intrathymic T cell maturation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Identification of Thy-1hiCD2Lin T cell progenitors in the adult bone marrow. C57BL/6 Ly5.2 bone marrow cells were enriched for Thy-1+ cells with immunomagnetic beads, and cells were subsequently stained for Thy-1 with one fluorochrome; TCRαβ, B220, Mac-1, and NK1.1 with a second fluorochrome; and CD2 with a third fluorochrome. Analysis of Thy-1 vs. B220, Mac-1, TCRαβ, and NK1.1 (A); the box encloses Thy-1hiTCRαβB220Mac-1NK1.1 (Thy-1hiLin) cells. The latter cells were gated and reanalyzed for Thy-1 vs. CD2 (B); boxes 1 and 2 enclose Thy-1hiCD2Lin and Thy-1hiCD2+Lin cells, respectively. Progenitor activity of sorted Thy-1hiCD2Lin Ly5.2 marrow cells was tested by incubating 5 × 104 cells with 4 × 106 Ly5.1 T cell-depleted marrow cells for 48 hr. The cultured cells were analyzed for CD4 and CD8 markers (C) or TCRαβ vs. Ly5.2 markers (D). Boxes enclose Ly5.2+ T cells. In a repeat experiment, the sorted Thy-1hiCD2Lin cells were cocultured with T cell-depleted Ly5.1 marrow cells, and cells were harvested at either 24 hr (E) or 48 hr (F). Gated Ly5.2+ cells harvested from the cultures were stained for TCRαβ vs. CD2, and boxes enclose CD2+TCRαβ (E) or CD2+TCRαβ+ (F) cells. The sorted Thy-1hiCD2Lin cells were also cocultured with whole instead of T cell-depleted Ly5.1 marrow cells, and cultures were stained for Ly5.2 vs. CD2 after 24 and 48 hr in G and H, respectively. Gated Ly5.2 cells from the latter cultures were stained for TCRαβ vs. CD2 at 24 and 48 hr (I and J, respectively), and boxes enclose CD2+TCRαβ+ cells. Expression of CD44 on sorted Thy-1hiCD2Lin cells before culture (K) is compared with that after coculture with T cell-depleted Ly5.1 marrow cells for 24 (L) or 48 hr (M). Analyses of CD44 vs. CD2 on gated Ly5.2 cells are shown, and boxes enclose CD44hiCD2+ cells. Each pair of profiles is from a separate representative experiment of at least four replicate experiments.
Figure 2
Figure 2
Progenitor activity of Thy-1hiCD16+CD2Lin sorted bone marrow cells. Enriched marrow cells from Ly5.2 mice were stained for Thy-1 vs. TCRαβ, B220, Mac-1, NK1.1, and CD2 vs. CD16 with three fluorochromes. The latter cells were analyzed for Thy-1 vs. TCRαβ, B220, Mac-1, NK1.1, and CD2 (A), and the box encloses Thy-1hiCD2Lin cells. Cells within the box in A were analyzed for Thy-1 vs. CD16 (B), and the box in B encloses Thy-1hiCD16+ cells. Single-color analysis of the intensity of staining of CD16 is also shown in the open areas of E and F also. The Thy-1hiCD16+ sorted cells (5 × 104) were cocultured with 4 × 106 T cell-depleted Ly5.1 marrow cells for 48 hr, and the newly generated CD4+ or CD8+ TCRαβ+Ly5.2 cells are enclosed in boxes in C and D. Cells were harvested also at 24 and 48 hr, gated on the Ly5.2+ subset, and analyzed for CD16 staining. The intensity of staining of the sorted cells before culture was compared with that after 24 hr (E) or after 48 hr (F). Open area shows staining before culture, and shaded area shows staining after culture.
Figure 3
Figure 3
CD4+CD8+ progeny of cultured T cell progenitors. Sorted Thy-1hiLin Ly5.2 marrow cells (2 × 104) were cultured with T cell-depleted Ly5.1 marrow cells (4 × 106), and cells were harvested at 44 and 48 hr (A, C, and B, D, respectively). At each time, Ly5.2+ cells were gated and analyzed for CD4/CD8 vs. TCRαβ (A and B) or CD4 vs. CD8 markers (C and D). In A and B, boxes enclose CD4+ and/or CD8+ TCRαβ+ T cells. In C and D, boxes enclose double-positive (CD4+CD8+) T cells.
Figure 4
Figure 4
Diagram of proposed alternative pathway of T cell maturation in the adult bone marrow. Thy-1hiTCRαβCD2CD16hi/intCD44hi progenitors rapidly mature into Thy-1hiTCRαβCD2+CD16int/−CD44int/− cells in association with TCR β chain gene rearrangement. Subsequently, TCR α chain gene rearrangement results in the development of CD4+CD8+ (double-positive) intermediary cells. Single-positive CD4+CD8 and CD4CD8+ T cells are derived from the double-positive cells during processes of positive and negative selection. The transition from Thy-1hiTCRαβCD2+ to CD4+CD8+ intermediary cells is arrested in the presence of mature T cells (feedback inhibition).

Similar articles

Cited by

References

    1. MacDonald H R, Lees R K, Bron C, Sordat B, Miescher G. J Exp Med. 1987;166:195–209. - PMC - PubMed
    1. Benveniste P, Chadwick B S, Miller R G, Reimann J. J Immunol. 1990;144:411–419. - PubMed
    1. Rocha B, Vassalli P, Guy-Grand D. J Exp Med. 1994;180:681–686. - PMC - PubMed
    1. Sato K, Ohtsuka K, Hasegawa K, Yamagiwa S, Watanabe H, Asakura H, Abo T. J Exp Med. 1995;182:759–767. - PMC - PubMed
    1. Leclercq G, Plum J. Leukemia. 1996;10:1853–1859. - PubMed

Publication types